AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALTERITY THERAPEUTICS LTD

0.008

-0.001-11.11%

Volume:12.98M

Turnover:100.48K

Market Cap:87.00M

PE:-4.21

High:0.008

Open:0.008

Low:0.007

Close:0.009

52wk High:0.017

52wk Low:0.006

Shares:10.88B

Float Shares:7.47B

Volume Ratio:0.24

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.002

EPS(LYR):-0.002

ROE:-43.23%

ROA:-28.09%

PB:2.05

PE(LYR):-4.21

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Hyperliquid price prediction bets HIP-4 can make outcome markets mainstream at a rich HYPE premium

XRP Price to $3? Mini Golden Cross Signals Momentum

Alterity Therapeutics Completes Phase 2 ATH434 Trial and Prepares for Phase 3 in MSA

Indonesia's Purbaya Attributes IHSG Gains to Foreign Investment Inflow

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ATH.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATH.AU\",,,,,undefined,":{"symbol":"ATH.AU","market":"AU","secType":"STK","nameCN":"ALTERITY THERAPEUTICS LTD","latestPrice":0.008,"timestamp":1770700320000,"preClose":0.009,"halted":0,"volume":12984397,"delay":0,"changeRate":-0.11111111111111102,"nameEN":"ALTERITY THERAPEUTICS LTD","floatShares":7474903343,"shares":10875416329,"eps":-0.001899,"marketStatus":"Closed","change":-0.001,"latestTime":"02-10 16:12:00 AEDT","open":0.008,"high":0.008,"low":0.007,"amount":100481,"amplitude":0.111111,"askPrice":0.008,"askSize":21401,"bidPrice":0.007,"bidSize":40017336,"shortable":3,"etf":0,"ttmEps":-0.001899,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.009,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.241801,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATH.AU\",,,,,undefined,":{"symbol":"ATH.AU","floatShares":7474903343,"roa":"-28.09%","roe":"-43.23%","lyrEps":-0.001899,"volumeRatio":0.241801,"shares":10875416329,"dividePrice":0,"high":0.008,"amplitude":0.111111,"preClose":0.009,"low":0.007,"week52Low":0.006,"pbRate":"2.05","psRate":"16.00","week52High":0.017,"institutionHeld":0,"latestPrice":0.008,"committee":0.998931,"eps":-0.001899,"divideRate":0,"volume":12984397,"delay":0,"ttmEps":-0.001899,"open":0.008,"prevYearClose":0.008,"prevWeekClose":0.009,"prevMonthClose":0.007,"prevQuarterClose":0.008,"fiveDayClose":0.008,"twentyDayClose":0.008,"sixtyDayClose":0.009},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATH.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATH.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608871081","title":"Hyperliquid price prediction bets HIP-4 can make outcome markets mainstream at a rich HYPE premium","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871081","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608871081?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:33","pubTimestamp":1770125589,"startTime":"0","endTime":"0","summary":"Hyperliquid price prediction HIP-4 expands outcome trading as HYPE trades far below its high, with rich valuations, heavy turnover, and skewed upside-downside risk.HIP-4 adds “outcome” contracts for prediction markets and bounded options-like trades, expanding HyperCore’s non-linear derivatives toolkit.HYPE sits near $32–$33 with ~$860m 24h volume, up over 300% in a year yet still roughly 40% below its ~$59 all-time high.Hyperliquid  is trying to turn “the perpification of everything” into a fullstack derivatives and predictionmarket machine, but the market is already pricing in a lot of perfection as price prediction seeks to court HYPE all-time highs.HyperCore will support outcome trading . Outcomes are fully collateralized contracts that settle within a fixed range. They are a general-purpose primitive that are useful for applications such as prediction markets and bounded options-like instruments. There has been…Structurally, the token is still well below its peak. CryptoRank and C","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/hyperliquid-price-prediction-bets-hip-4-can-make-outcome-markets-mainstream-at-a-rich-hype-premium/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/hyperliquid-price-prediction-bets-hip-4-can-make-outcome-markets-mainstream-at-a-rich-hype-premium/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["ATH.AU","BK4162","ATH","BK7067"],"gpt_icon":0},{"id":"2606506852","title":"XRP Price to $3? Mini Golden Cross Signals Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2606506852","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606506852?lang=en_us&edition=fundamental","pubTime":"2026-01-24 15:21","pubTimestamp":1769239260,"startTime":"0","endTime":"0","summary":"XRP has been stuck over the last 30 days, with the price failing to breach the $2.50 resistance level. However, technical signals suggest that a breakout to reclaim $3 could happen if ecosystem bulls ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/xrp-price-to-3-mini-golden-cross-signals-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/xrp-price-to-3-mini-golden-cross-signals-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BK4162","XRP","ATH.AU","ATH","BK7067","RSI","BK4150"],"gpt_icon":0},{"id":"2605510436","title":"Alterity Therapeutics Completes Phase 2 ATH434 Trial and Prepares for Phase 3 in MSA","url":"https://stock-news.laohu8.com/highlight/detail?id=2605510436","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605510436?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:25","pubTimestamp":1768998316,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics Ltd. announced the successful completion of its Phase 2 program for its lead asset, ATH434, in multiple system atrophy . The company reported that results from the Phase 2 trials demonstrated ATH434 to be safe and well-tolerated, with strong signals of efficacy in an indication that currently has no approved disease-modifying treatments. Alterity stated it is now advancing ATH434 towards a pivotal Phase 3 clinical program in MSA, targeting entry into an estimated $2.4 billion market opportunity. The company outlined three key objectives for 2026: finalizing the regulatory strategy to initiate the Phase 3 trial, deepening external engagement, and expanding intellectual property protection. An End-of-Phase 2 meeting with the FDA is planned for mid-2026, which will be the final regulatory step before the Phase 3 trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL56jMRF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","ATH.AU","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","BK7067","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4588","SG9999014013.SGD","NDAQ"],"gpt_icon":0},{"id":"2604194916","title":"Indonesia's Purbaya Attributes IHSG Gains to Foreign Investment Inflow","url":"https://stock-news.laohu8.com/highlight/detail?id=2604194916","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604194916?lang=en_us&edition=fundamental","pubTime":"2026-01-20 16:50","pubTimestamp":1768899038,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-Indonesia's Minister of Finance, Purbaya Yudhi Sadewa, said foreign investments influenced the strengthening of IDX Composite Index . \"In the last three months, the foreign capital inflow has been positive,\" said Purbaya at the parliament complex on Monday, January 19, 2026.According to Purbaya, IHSG saw a surge because investors have seen the economic perspective and reviewed government policies. \"IHSG surges not because of foolish market players. These people are intelligent,\" he said.On Monday afternoon, January 19, 2026, IHSG closed at an all-time-high  record at9,133.87, while Rupiah weakened to Rp16,955 per US dollar.","market":"nz","thumbnail":"https://statik.tempo.co/data/2026/01/14/id_1453223/1453223_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/01/14/id_1453223/1453223_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2081694/indonesias-purbaya-attributes-ihsg-gains-to-foreign-investment-inflow","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2081694/indonesias-purbaya-attributes-ihsg-gains-to-foreign-investment-inflow","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["ATH.AU","BK4162","BK7067","ATH"],"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ATH.AU\",params:#limit:6,delay:true,,,undefined,":[]}}